Jordan Harry’s Conversation on Cancer and Clot Risk with Thrombosis Canada
Jordan Harry, Summer Research Assistant at Providence Care, shared a proud post on LinkedIn:
“Just Released — My Conversation on Cancer and Clot Risk with Thrombosis Canada
I recently had the opportunity to join CLOT Conversations, a podcast by Thrombosis Canada, to talk about our recent research on cancer-associated thrombosis – a serious but often overlooked complication in oncology care.
In the episode, we cover:
-Which solid cancers carry the highest risk of VTE
-How sex and geography influence risk
-What this means for patient care and what needs to change
This work was made possible by an incredible team: Regan Bucciol, Deirdre Finnigan, Hussein Hashem, and Ahmad Alaraki, MBBS. Thank you for your insight and dedication throughout the project.
A special thanks to Dr. Maha Othman MD MSc PhD., whose mentorship and guidance
made this work possible from day one.
Grateful to Thrombosis Canada for the opportunity to share our findings, and to St. Lawrence College and Queen’s University for supporting this work.”
Listen to the episode.
Read the Publication.
Article: The incidence of venous thromboembolism by type of solid cancer worldwide: A systematic review
Authors: Jordan Harry, Regan Bucciol, Deirdre Finnigan, Hussein Hashem, Ahmad Araki, Maha Othman
Stay updated on all science in the field with Hemostasis Today.
-
Aug 14, 2025, 23:47World Thrombosis Day: Know your Risk in DVT
-
Aug 14, 2025, 12:52JAMA Review: Immune Thrombotic Thrombocytopenic Purpura (iTTP)
-
Aug 14, 2025, 12:33Louise Bannon: The World Thrombosis Day Campaign is Calling on Industry Leaders
-
Aug 14, 2025, 10:58Thomas Reiser: Why October 13 Marks World Thrombosis Day?
-
Aug 14, 2025, 04:03Perioperative Thrombotic Risk Guide for Hematology Fellows
-
Aug 14, 2025, 23:47Health-related Quality of Life in Children with von Willebrand Disease
-
Aug 14, 2025, 17:54Omid Seidizadeh: From Genotype and Phenotype! Variability in Type 2 von Willebrand Disease
-
Aug 14, 2025, 17:36Samin Mohsenian: Thrombotic Paradox in Congenital Fibrinogen Deficiencies
-
Aug 14, 2025, 17:10Emmanuel J Favaloro: DOACs and Mechanical Coagulation Test Systems
-
Aug 14, 2025, 13:09Thrombin Generation Assay to Guide Factor Therapy With Fitusiran
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot